Patient recruitment has often focused on traditional media methods like TV, newspaper, and radio, which often lead to a low recruitment conversion rate. Digital patient..Learn More
We are proud to announce that EvidentIQ is joining forces with Novo Nordisk to present the Open Study Builder at the Digital Data Flow (DDF) connect-a-thon. This DDF..Learn More
Want to save time and enhance your clinical trials? Learn how to take your data capture to the next level thanks to our tips and..Learn More
July 4th, 2022, Hamburg (GERMANY). This merger will strengthen their portfolio and help bring EvidentIQ’s offer to yet another level of expertise. Today, EvidentIQ, a..Learn More
In collaboration with DT Consulting, Carenity*, part of EvidentIQ, conducted a survey of patients whose primary condition was ankylosing spondylitis, bipolar disorder, breast cancer, chronic..Learn More
In collaboration with DT Consulting, Carenity*, part of EvidentIQ, conducted a survey of patients from France, Germany, Italy, Spain, the UK, and the US to..Learn More
Innovative Real-World-Evidence generation to efficiently combine digital biomarkers and self-reported..
How to leverage data linkage to get better outcomes? EvidentIQ, a leading clinical data science group, announced its partnership with Feel Therapeutics, a digital therapeutics..Learn More